Glucagon-Like Peptide-1 Receptor Agonists and Incident Cardiovascular Events and Death in Treated Serious Mental Illness, Type 2 Diabetes, and Obesity.
Journal of the American Heart Association · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
HumansDiabetes Mellitus, Type 2MaleFemaleGlucagon-Like Peptide-1 Receptor AgonistsObesityRetrospective StudiesMental DisordersMiddle AgedSemaglutideTirzepatideIncidenceAgedAntipsychotic AgentsHypoglycemic AgentsMyocardial InfarctionHeart FailureUnited StatesCause of DeathRisk AssessmentGlucagon-Like PeptidesIncretinsRisk FactorsAdultCardiovascular DiseasesTime FactorsAntidepressive Agentscardiovascular outcomesdeathglucagon‐like peptide‐1 receptor agonistsheart failuremyocardial infarctionobesitysemaglutideserious mental illnesstirzepatidetype 2 diabetes
Come citare questo studio
Samuel B Governor, David M Dávila-García, Eliut Rivera-Segarra, Lindsey M Filiatreau, Nelmit Tollinchi-Natali, Ekow Essien, Osamah Altaee, Prince Otchere, Leopoldo J Cabassa, Victor G Dávila-Román. (2026). Glucagon-Like Peptide-1 Receptor Agonists and Incident Cardiovascular Events and Death in Treated Serious Mental Illness, Type 2 Diabetes, and Obesity.. Journal of the American Heart Association. DOI: 10.1161/jaha.126.051982
Consulta la pubblicazione originale ↗